Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
12/2009
12/16/2009CN100569739C Compound N-((2R,3S,E)-1,3-dihydroxy-17-methyloctadecyl-8-en-2-yl)acetamide
12/16/2009CN100569738C Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
12/16/2009CN100569737C Method for the purification of dimethylacetamide (DMAc)
12/16/2009CN100569736C Process for producing amino acid derivatives
12/16/2009CN100569735C Technique for synthesizing o-chloroacetaminophenol
12/16/2009CN100569733C Method for continuously producing alkylamino(meth)acrylamides
12/15/2009US7632972 Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells
12/15/2009US7632971 Method of crystallization of bicalutamide
12/15/2009US7632929 hapten compounds comprising either methamphetamine or amphetamine conjugated to a linker; therapy for drug overdose, decreases the concentration of methamphetamine, amphetamine, or MDMA in the brain of the subject
12/15/2009US7632866 Meclofenamic acid derivatives, for example; useful in the treatment of conditions such as central or peripheral nervous system disorders through the modulation of potassium ion flux through voltage-dependent potassium channels and/or depressing cortical and/or peripheral neuron activity
12/15/2009US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions
12/15/2009US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS
12/15/2009US7632531 such as 2,6-nonadienamide,N-2-propenyl-,(2E,6Z); organoleptic; for addition to foods, beverages, medicine, and toothpaste
12/15/2009CA2470977C Phase change inks containing branched triamides
12/15/2009CA2373180C Propanoic acid derivatives that inhibit the binding of integrins to their receptors
12/10/2009WO2009147383A1 Process for the synthesis of arformoterol
12/10/2009WO2009147141A2 Monoetherified diols of diamondoids
12/10/2009WO2009146648A1 Amide compounds, preparation methods and uses thereof
12/10/2009WO2009146539A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
12/10/2009WO2009075561A3 Process for the preparation of fluorinated quaternary ammonium salts
12/10/2009WO2009073138A3 Treatment of metabolic syndrome with novel amides
12/10/2009WO2009015369A3 Isophthalamide derivatives inhibiting beta-secretase activity
12/10/2009WO2008152333A9 Novel derivatives of 3-phenyl propanoic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions
12/10/2009US20090306215 Deuterium-enriched arformoterol
12/10/2009US20090306214 Use of Syk Tyrosine Kinase Inhibitors for the Treatment of Cell Proliferative Disorders
12/10/2009US20090306213 Process for Synthesis of Glycomimicking Cationic Amphiphiles
12/10/2009US20090306109 Fungicide active substance combinations
12/10/2009US20090306078 Compounds that inhibit hif-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component
12/10/2009US20090305196 Dental compositions including organogelators, products, and methods
12/10/2009CA2724882A1 Process for the synthesis of arformoterol
12/10/2009CA2722723A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
12/09/2009EP2129652A2 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
12/09/2009EP2129219A1 Substituted fused-ring compounds for inflammation and immune-related uses
12/09/2009EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009EP1392642B1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
12/09/2009CN101600713A Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV
12/09/2009CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor
12/09/2009CN100567257C Functional monomers, process for preparing dispersants therewith, dispersants and lubricating oil compositions containing the dispersants
12/08/2009US7629493 purifying the antiarrhythmia agent; by dissolving in water mixture which is saturated with at least one water-immiscible solvent and water-miscible solvents, to crystallize at a low temperature; produce on large industrial scales
12/08/2009US7629368 Nitroderivatives as drugs for diseases having an inflammatory basis
12/08/2009US7629367 Tissue-selective androgen receptor modulators (SARMs); male hypogonadism, prostate cancer, benign prostate hyperplasia, sarcopenia, rheumatoid arthritis and osteoarthritis; N-((5-cyclopropyl-2-fluoropyridin-3-yl)methyl)-2-phenylbutanamide for example
12/08/2009CA2424396C Naphthylsalicylanilides as antimicrobial and antiinflammatory agents
12/08/2009CA2422342C Novel amide derivatives and medicinal use thereof
12/03/2009WO2009145263A1 Process for producing oseltamivir phosphate and intermediate compound
12/03/2009WO2009144736A1 NOVEL PROCESS FOR THE PREPARATION OF 4-FLUORO-ALPHA-[2-METHYL -1-OXOPROPYL]-GAMMA-OXO-N-ß-DIPHENYLBENZENEBUTANAMIDE AND PRODUCTS THEREFROM
12/03/2009WO2009143715A1 Retinoid derivative and pharmaceutical composition and use thereof
12/03/2009WO2009125409A3 Fatty acid amides and uses thereof
12/03/2009WO2009121485A8 Continuous method for producing fatty acid alkanol amides
12/03/2009WO2009110002A4 Novel efflux pump inhibitors
12/03/2009WO2009108017A3 New pyruvate derivatives with neuroprotective effect, process for preparing the same and pharmaceutical composition comprising the same
12/03/2009WO2009088831A3 Method of inhibiting abcg2 and other treatment methods
12/03/2009WO2009075560A3 Process for the preparation of fluorinated acrylic derivatives
12/03/2009US20090299097 Method for Producing 1-Formamido-3,5-Dimethyladamantane
12/03/2009US20090299096 Amidoadamantanes and Method for Producing the Same
12/03/2009US20090298949 Aminoalkylphenols, methods of using and making the same
12/03/2009US20090298907 Reacting 2-halo-1-(4-fluorophenyl)-2-phenone of formula II with 4-methyl-3-oxo-N-phenylpentamide; high purity and good yield; for the synthesis of atorvastatin
12/03/2009US20090298899 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); {3-[(4-Chloro-biphenyl-3-carbonyl)-amino]-phenyl}-acetic acid; glaucoma or ocular hypertension; dysmenorrhoea, preterm labour, immune disorders, inflammatory disorders
12/03/2009US20090298898 Pesticidally active ketone and oxime derivatives
12/03/2009US20090298834 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
12/03/2009US20090297424 Continuous method and apparatus of functionalizing carbon nanotube
12/03/2009DE102008027133A1 Vollsynthetisches Albumin-Analogon Fully synthetic albumin analogue
12/02/2009EP2128610A2 Ingestibles possessing intrinsic color change
12/02/2009EP2125704A1 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
12/02/2009EP2125703A2 New n-(3-phenylpropyl)benzamide derivatives
12/02/2009EP1812399B1 Opiate intermediates and methods of synthesis
12/02/2009EP1581477B1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
12/02/2009EP1446380B1 Formoterol tartrate process and polymorph
12/02/2009CN101595084A Biaryl compositions and methods for modulating a kinase cascade
12/02/2009CN101591263A Method for preparing N-ethyl-2-isopropyl-5-methycyclohexane
12/02/2009CN101591262A Method for extracting ceramide amphoteric lipid from agriculture-forestry byproducts
12/02/2009CN100564344C 2- and 2,5-substituted phenylketo-enols
12/01/2009US7626056 2,4-Dichloro-N-(4-cyclopropylmethanesulfonyl-1-cyclopropylmethylcyclohexyl-methyl) benzamide; glutamatergic neurotransmission dysfunction and diseases; dementia; antidepressants; learning enhancement; cognition activators; attention deficit disorders; autism; eating disorders; anxiolytic agents
12/01/2009US7626055 2,4-diChloro-N-(4-cyclopropylmethanesulfonyl-1-cyclopropylmethylcyclohexyl-methyl) benzamide; glutamatergic neurotransmission dysfunction and diseases; dementia; antidepressants; learning enhancement; cognition activators; attention deficit disorders; autism; eating disorders; anxiolytic agents
12/01/2009US7625988 Maintain flexibility
12/01/2009US7625948 Ester that inhibits MTP in intestines as antilipemic agents for side effect reduction
12/01/2009CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
12/01/2009CA2170806C Tricyclic derivatives, process for preparing the same, their use for preparing optically active colchicine and thiocolchicine or racemates thereof, and analogs, derivatives and intermediates
11/2009
11/26/2009WO2009118493A3 Method for the continuous synthesis of an n-acylated compound, and equipment for implementing said method
11/26/2009WO2009080722A3 Carboxylic derivatives for use in the treatment of cancer
11/26/2009US20090292025 Novel crystalline forms of armodafinil and preparation thereof
11/26/2009US20090292001 Tricyclic derivatives as potent and selective histone deacetylase inhibitors
11/26/2009US20090291998 Eponemycin and epoxomicin analogs and uses thereof
11/26/2009US20090291970 Substituted Aminoethers for the Treatment of Alzheimer's Disease
11/25/2009EP2123665A2 Inhibitors of interleukin-1Beta converting enzyme
11/25/2009EP2123176A1 Acylamino acid compounds and food preparations containing same
11/25/2009EP2121674A1 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
11/25/2009EP2121580A2 N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases
11/25/2009EP2121579A1 Malonamides as orexin antagonists
11/25/2009EP2121576A1 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
11/25/2009EP2120559A1 Substituted phenylamidines and the use thereof as fungicides
11/25/2009EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides
11/25/2009CN101589028A Process for production of phenylalanine derivatives having quinazolinedione skeletons and intermediates for the production
11/25/2009CN101585780A Method for asymmetric synthesis of chiral paclitaxel lateral chain
11/25/2009CN101585779A New crystal form of Agomelatine, preparation method and use thereof
11/25/2009CN100562515C 2-halogen-6-alkyl-phenyl substituted tetramic acid derivatives
11/24/2009US7622612 Tricyclic derivatives and their use
11/24/2009US7622611 N-(5-methanesulfonyl-2-methyl-4-pentafluorosulfanylbenzoyl)guanidine; antiarrhythmic medicaments with cardioprotective component for prophylaxis and treatment of infarction and angina pectoris; also inhibit preventively pathophysiological processes associated with development of ischemia-induced damage
11/24/2009US7622610 Topical, oily skin disorders such as acne; N-benzyl-N'-(2,6-diisopropyl-phenyl)-N-isopropyl-malonamide
11/24/2009US7622483 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis
11/24/2009US7622467 Aryl aniline derivatives as β2 adrenergic receptor agonists
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 289